Profound Medical Corp.
PRN.TO
TSX
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -20.73% | -22.64% | |||
Total Other Revenue | -13.33% | -31.91% | |||
Total Revenue | -15.64% | -29.26% | |||
Cost of Revenue | -22.79% | -34.97% | |||
Gross Profit | -12.68% | -26.58% | |||
SG&A Expenses | 13.58% | 24.45% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 16.17% | 10.61% | |||
Operating Income | -23.64% | -27.48% | |||
Income Before Tax | -46.32% | -91.73% | |||
Income Tax Expenses | 56.10% | 117.23% | |||
Earnings from Continuing Operations | -46.35% | -101.05% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -46.35% | -101.05% | |||
EBIT | -23.64% | -27.48% | |||
EBITDA | -24.19% | -31.22% | |||
EPS Basic | -46.27% | -72.46% | |||
Normalized Basic EPS | -46.24% | -64.54% | |||
EPS Diluted | -46.27% | -72.46% | |||
Normalized Diluted EPS | -46.24% | -64.54% | |||
Average Basic Shares Outstanding | 0.04% | 16.57% | |||
Average Diluted Shares Outstanding | 0.04% | 16.57% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |